These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 24634186)

  • 1. Mechanism of the reversal effect of mifepristone on drug resistance of the human cervical cancer cell line HeLa/MMC.
    Chen H; Duan J; Zuo F
    Genet Mol Res; 2014 Feb; 13(1):1288-95. PubMed ID: 24634186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mifepristone modulates glucosylceramide synthase expression and reverse multidrug resistance in ovarian cancer cells].
    Liu Y; Wang LL
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1727-30. PubMed ID: 18819906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GCS induces multidrug resistance by regulating apoptosis-related genes in K562/AO2 cell line.
    Liu Y; Xie KM; Yang GQ; Bai XM; Shi YP; Mu HJ; Qiao WZ; Zhang B; Xie P
    Cancer Chemother Pharmacol; 2010 Aug; 66(3):433-9. PubMed ID: 19936984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Enhanced sensitivity of ovarian cell line to cisplatin induced by mifepristone and its mechanism].
    Qin TN; Wang LL
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Apr; 22(4):344-6. PubMed ID: 12390742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. REV3L, a promising target in regulating the chemosensitivity of cervical cancer cells.
    Yang L; Shi T; Liu F; Ren C; Wang Z; Li Y; Tu X; Yang G; Cheng X
    PLoS One; 2015; 10(3):e0120334. PubMed ID: 25781640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on the reversion of drug resistance in human cervical cancer cell lines].
    Chen H; Chen H; Wu X
    Zhonghua Fu Chan Ke Za Zhi; 2001 Nov; 36(11):669-71. PubMed ID: 11930693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas.
    Herr I; Ucur E; Herzer K; Okouoyo S; Ridder R; Krammer PH; von Knebel Doeberitz M; Debatin KM
    Cancer Res; 2003 Jun; 63(12):3112-20. PubMed ID: 12810637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Induction of apoptosis by mifepristone in androgen-independent prostate cancer cell lines in vitro].
    Zhang H; Lü JJ; Gao QZ; Zhang J
    Zhonghua Wai Ke Za Zhi; 2006 Mar; 44(6):382-5. PubMed ID: 16638347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisplatin cytotoxicity is increased by mifepristone in cervical carcinoma: an in vitro and in vivo study.
    Jurado R; Lopez-Flores A; Alvarez A; García-López P
    Oncol Rep; 2009 Nov; 22(5):1237-45. PubMed ID: 19787245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stat3 activation in human endometrial and cervical cancers.
    Chen CL; Hsieh FC; Lieblein JC; Brown J; Chan C; Wallace JA; Cheng G; Hall BM; Lin J
    Br J Cancer; 2007 Feb; 96(4):591-9. PubMed ID: 17311011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study of effect of mifepristone on apoptosis of human ovarian cancer cell line 3AO].
    Li Q; Li JJ; Zhao XB; Ji M
    Zhonghua Fu Chan Ke Za Zhi; 2003 Oct; 38(10):625-8. PubMed ID: 14728868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines.
    Henkels KM; Turchi JJ
    Cancer Res; 1999 Jul; 59(13):3077-83. PubMed ID: 10397248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of tamoxifen sensitivity by antisense Bcl-2 and trastuzumab in breast carcinoma cells.
    Kim R; Tanabe K; Emi M; Uchida Y; Toge T
    Cancer; 2005 May; 103(10):2199-207. PubMed ID: 15830342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of glucosylceramide synthase in associated with multidrug resistance of leukemia cells.
    Xie P; Shen YF; Shi YP; Ge SM; Gu ZH; Wang J; Mu HJ; Zhang B; Qiao WZ; Xie KM
    Leuk Res; 2008 Mar; 32(3):475-80. PubMed ID: 17709137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of apoptosis-related proteins in advanced uterine cervical cancer after balloon-occluded arterial infusion chemotherapy as an indicator of the efficiency of this therapy.
    Okamoto E; Sumi T; Misugi F; Nobeyama H; Hattori K; Yoshida H; Matsumoto Y; Yasui T; Honda K; Ishiko O
    Int J Mol Med; 2005 Jan; 15(1):41-7. PubMed ID: 15583826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP.
    Zhu W; Xu H; Zhu D; Zhi H; Wang T; Wang J; Jiang B; Shu Y; Liu P
    Cancer Chemother Pharmacol; 2012 Mar; 69(3):723-31. PubMed ID: 21993663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis induction of oroxylin A in human cervical cancer HeLa cell line in vitro and in vivo.
    Li HN; Nie FF; Liu W; Dai QS; Lu N; Qi Q; Li ZY; You QD; Guo QL
    Toxicology; 2009 Mar; 257(1-2):80-5. PubMed ID: 19135124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antisense Bcl-2 and HER-2 oligonucleotide treatment of breast cancer cells enhances their sensitivity to anticancer drugs.
    Tanabe K; Kim R; Inoue H; Emi M; Uchida Y; Toge T
    Int J Oncol; 2003 Apr; 22(4):875-81. PubMed ID: 12632082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical evaluation of a new liposomal formulation of cisplatin, lipoplatin, to treat cisplatin-resistant cervical cancer.
    Casagrande N; De Paoli M; Celegato M; Borghese C; Mongiat M; Colombatti A; Aldinucci D
    Gynecol Oncol; 2013 Dec; 131(3):744-52. PubMed ID: 24029417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the proapoptotic regulator Bcl2/adenovirus EIB 19 kDa-interacting protein 3 on radiosensitivity of cervical cancer.
    Wang Z; Huang CM; Deng Q; Zeng H; Wang X; Zhang S; Bi F; Tang QL; Zhong RM; Li AJ; He YB; Chen N; Li ZP; Wang W
    Cancer Biother Radiopharm; 2011 Jun; 26(3):279-86. PubMed ID: 21711117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.